Jammu, Oct. 9 -- Share Tweet Share New Delhi, Oct 9 (KNS): Prices of several anti-cancer medicines could fall by as much as 70 per cent as the Central government moves to cap trade margins on non-scheduled cancer drugs at 30 per cent of their Maximum Retail Price (MRP), a measure expected to provide substantial financial relief to patients undergoing cancer treatment. According to a report by India TV, citing official sources, the proposed intervention is aimed at curbing excessive trade mark-ups on expensive cancer medicines and reducing the out-of-pocket expenditure borne by patients and their families. The government estimates that the proposed pricing intervention could result in annual savings of approximately Rs 2,500 crore for pati...